ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Philips highlights AI-powered integrated diagnostic approach at ECR 2023

March 1, 2023

Fully interoperable smart imaging systems and informatics solutions connect teams in radiology, oncology, cardiology and pathology to enhance clinical confidence and advance precision in diagnosis and treatment

Vienna, Austria and Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its radiology portfolio of smart connected imaging systems and vendor-neutral integrated radiology workflow solutions featured at the European Congress of Radiology (ECR) international meeting (March 1-5, Vienna, Austria). Visitors to Philips @The Blue Level at ECR, the largest exposition space at the Congress, will experience how Philips’ AI-powered technology turns data into actionable insights to increase diagnostic confidence and improve clinical outcomes, enhancing patient and staff experience, driving operational efficiency, and helping lower the cost of care.

“At this year’s ECR, together with our customer partners, Philips will demonstrate how our latest AI-powered integrated smart diagnostic systems and informatics solutions can help reduce clinical complexity and drive operational efficiency to address workforce shortages and staff burnout, all while optimizing the right care pathway for patients,” said Bert van Meurs, Chief Business Leader of Image Guided Therapy and Precision Diagnosis at Philips. “With our AI-enabled technology, we can automate and accelerate routine tasks to generate patient-centric insights from large volumes of data to help improve productivity and enhance patient outcomes. Underpinning each of our innovations at ECR is Philips’ commitment to delivering sustainable, resilient diagnostic solutions that help hospitals receive ongoing value from their investments.”

Smart connected imaging systems powered by leading clinical and AI technology
Philips will showcase its latest innovations connecting radiology, cardiology, pathology and oncology across MR, CT, diagnostic X-ray and ultrasound, including MR SmartSpeed, the next-generation imaging technology that leverages Philips’ state-of-the-art speed engine and an award-winning Artificial Intelligence (AI) [1] reconstruction technology that boosts speed and image quality. In partnership with Leiden University Medical Center (Leiden, The Netherlands) Philips is innovating with AI to further speed up and improve MR examinations, with the aim to reduce scan times to less than five minutes and to reconstruct detailed MR images despite patient or internal organ movement. The approach is already showing promising results in leading hospitals worldwide.

“In systematic research studies, we have seen strong evidence of the ability of SmartSpeed to significantly accelerate acquisition times for knee and spine examinations without compromising image quality, with scan times that can be reduced up to 64% for certain sequences,” said Dr. Andra-Iza Iuga, Department of Radiology at the University Hospital of Cologne, Germany.  “Since musculoskeletal (MSK) exams make up a large part of all MR procedures, these acceleration benefits have the potential to result in significant operational cost reductions and we are currently successfully implementing the results of our research studies into our clinical routine.”

Integrated radiology workflow solutions driving operational efficiency
Optimizing clinical workflows can help eliminate waste and allow hospitals to use their resources more efficiently, which translates into improved patient flow and delivery of higher quality care to patients. At ECR, Philips will spotlight its advanced technology to simplify and connect workflows to help reduce variability and staff workload, drive operational efficiency, and enhance the patient experience.

For more information on Philips’ fully integrated radiology portfolio of imaging and informatics solutions being featured at ECR, visit the Philips ECR Press Backgrounder. Read more about Philips’ partnerships with public and private customers, peers, and industry-leading global organizations to help reduce the environmental impact of radiology.

Join Philips in person at the Blue Level at ECR, or virtually via the Philips interactive online radiology experience and follow @PhilipsLiveFrom for #ECR2023 updates throughout the event.

[1] According to the definition of AI from the EU High-Level Expert Group. 

For further information, please contact:

Kathy O’Reilly 
Philips Global Press Office 
Tel.:+1 978 221 8919 
E-Mail: kathy.oreilly@philips.com 
Twitter: @kathyoreilly 

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.25
+2.28 (1.00%)
AAPL  269.00
+0.19 (0.07%)
AMD  258.01
-1.66 (-0.64%)
BAC  52.87
-0.15 (-0.28%)
GOOG  268.43
-1.50 (-0.56%)
META  751.44
+0.62 (0.08%)
MSFT  542.07
+10.55 (1.98%)
NVDA  201.03
+9.54 (4.98%)
ORCL  280.83
-0.57 (-0.20%)
TSLA  460.55
+8.13 (1.80%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.